American researchers have discovered a significant link between the life expectancy of ovarian cancer patients and the levels of two key enzymes in the body. According to a recent report from the Spanish newspaper *Le Monde*, scientists at the MD Anderson Cancer Center in the U.S. analyzed 111 and 132 ovarian cancer samples, respectively. Their findings revealed that patients with high levels of the enzymes Dicer and Drosha had an average survival time of 11 years, while those with lower levels lived only about 2.86 years on average.
Gabriel Lopes-Bellestein, one of the study’s authors, emphasized the importance of Dicer levels in predicting outcomes for ovarian cancer patients. He stated, "We found that the level of Dicer is especially critical for patients with ovarian cancer. This discovery could significantly improve both diagnosis and treatment strategies for this disease."
The research, which was published in the *New England Journal of Medicine* on the 18th, highlights the potential for using these enzymes as biomarkers to better tailor treatment plans. By understanding how Dicer and Drosha function in cancer progression, doctors may be able to develop more personalized therapies, ultimately improving patient outcomes. This study represents an important step forward in the ongoing fight against ovarian cancer, offering new hope for patients and medical professionals alike.
Gelatin Size 0 Empty Capsule,Empty Shell Gelatin Capsule,Empty Gelatin Color Hard Capsules,Colorful Capsule Empty Gelatin
Ningbo Jiangnan Capsule Co., Ltd. , https://www.jncapsule.com